Northern Trust’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.8M | Sell |
634,326
-22,407
| -3% | -$1.2M | ﹤0.01% | 1326 |
|
2025
Q1 | $26.6M | Buy |
656,733
+36,412
| +6% | +$1.47M | ﹤0.01% | 1462 |
|
2024
Q4 | $17.3M | Buy |
620,321
+35,737
| +6% | +$994K | ﹤0.01% | 1790 |
|
2024
Q3 | $16.8M | Sell |
584,584
-3,282
| -0.6% | -$94.2K | ﹤0.01% | 1737 |
|
2024
Q2 | $13.8M | Sell |
587,866
-9,822
| -2% | -$230K | ﹤0.01% | 1807 |
|
2024
Q1 | $15.1M | Buy |
597,688
+57,003
| +11% | +$1.44M | ﹤0.01% | 1791 |
|
2023
Q4 | $12.6M | Buy |
540,685
+2,662
| +0.5% | +$62.2K | ﹤0.01% | 1911 |
|
2023
Q3 | $27.2M | Buy |
538,023
+77,594
| +17% | +$3.92M | 0.01% | 1336 |
|
2023
Q2 | $21.5M | Buy |
460,429
+102,662
| +29% | +$4.79M | ﹤0.01% | 1535 |
|
2023
Q1 | $13.7M | Sell |
357,767
-2,510
| -0.7% | -$96K | ﹤0.01% | 1807 |
|
2022
Q4 | $19.7M | Buy |
360,277
+95,767
| +36% | +$5.25M | ﹤0.01% | 1528 |
|
2022
Q3 | $9.01M | Buy |
264,510
+20,232
| +8% | +$689K | ﹤0.01% | 2051 |
|
2022
Q2 | $2.31M | Buy |
244,278
+8,353
| +4% | +$79K | ﹤0.01% | 2977 |
|
2022
Q1 | $3.35M | Sell |
235,925
-13,849
| -6% | -$196K | ﹤0.01% | 2819 |
|
2021
Q4 | $5.28M | Buy |
249,774
+2,831
| +1% | +$59.9K | ﹤0.01% | 2640 |
|
2021
Q3 | $5.52M | Sell |
246,943
-10,069
| -4% | -$225K | ﹤0.01% | 2661 |
|
2021
Q2 | $6.38M | Buy |
257,012
+83,012
| +48% | +$2.06M | ﹤0.01% | 2696 |
|
2021
Q1 | $5.05M | Sell |
174,000
-12,968
| -7% | -$376K | ﹤0.01% | 2735 |
|
2020
Q4 | $4.82M | Sell |
186,968
-5,116
| -3% | -$132K | ﹤0.01% | 2706 |
|
2020
Q3 | $5.91M | Buy |
192,084
+38,032
| +25% | +$1.17M | ﹤0.01% | 2421 |
|
2020
Q2 | $3.84M | Buy |
154,052
+54,190
| +54% | +$1.35M | ﹤0.01% | 2678 |
|
2020
Q1 | $2.12M | Buy |
99,862
+30,701
| +44% | +$651K | ﹤0.01% | 2824 |
|
2019
Q4 | $1.54M | Sell |
69,161
-775
| -1% | -$17.2K | ﹤0.01% | 3246 |
|
2019
Q3 | $1.59M | Buy |
69,936
+58,608
| +517% | +$1.33M | ﹤0.01% | 3224 |
|
2019
Q2 | $217K | Buy |
+11,328
| New | +$217K | ﹤0.01% | 3800 |
|